IDH1 and central nervous system cancer: However, in these studies, TERT mRNA expression was used as a surrogate for TERT mutational status in a considerable number of cases and, therefore, were not conclusive in their evaluation of the value of TERT promoter mutation as an independent prognostic marker in IDH-mutated gliomas [12, 19].